Market Tracker

11/25 3:46pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

80.45
Data as of 3:30pm ET
 +1.37 / +1.73%
Today’s Change
55.61
Today|||52-Week Range
119.42
+24.30%
Year-to-Date

Today’s Trading

Previous close79.08
Today’s open79.50
Day’s range78.69 - 80.73
Volume253,806
Average volume (3 months)255,522
Market cap$2.6B
Dividend yield--
Data as of 3:30pm ET, 11/25/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-72.72%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book5.66

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp-0.48-1.81%
KITEKite Pharma Inc-1.96-4.26%
OPHTOphthotech Corp+0.04+0.09%
NVAXNovavax Inc-0.01-0.29%
Data as of 3:46pm ET, 11/25/2014

Financials

Next reporting dateMarch 9, 2015
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts